BioSpace News Archive

Business

Hologic Announces Financial Results for Fourth Quarter of Fiscal 2017

Revenue of $802.9 million increased 10.5%, or 9.9% in constant currency, compared to the prior year period. Excluding the net impact of the Cynosure acquisition and blood screening divestiture, fourth-quarter revenue increased 5.0%, or 4.4% in constant currency.

November 8, 2017
·
86 min read
Business

Viking Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update

Research and development expenses for the three months ended September 30, 2017 were $3.5 million compared to $2.1 million for the same period in 2016.

November 8, 2017
·
19 min read
Business

Genomic Health Announces Third Quarter 2017 Financial Results and Reports Recent Business Progress

Total revenue was $83.8 million in the third quarter of 2017, compared with $82.3 million in the third quarter of 2016.

November 8, 2017
·
24 min read
Business

Aerie Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update

As of September 30, 2017, Aerie had cash, cash equivalents and investments of $282.2 million.

November 8, 2017
·
14 min read
Business

Zymeworks Reports Third Quarter 2017 Financial Results and Provides Business Update

Revenues for the three months ended September 30, 2017 were $0.1 million compared to $2.2 million for the same period of 2016.

November 8, 2017
·
7 min read